LBX Pharmacy Chain Joint Stock Company

SHSE:603883 Stock Report

Market Cap: CN¥13.8b

LBX Pharmacy Chain Past Earnings Performance

Past criteria checks 2/6

LBX Pharmacy Chain has been growing earnings at an average annual rate of 12.2%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 15.3% per year. LBX Pharmacy Chain's return on equity is 13.4%, and it has net margins of 3.7%.

Key information

12.2%

Earnings growth rate

9.2%

EPS growth rate

Consumer Retailing Industry Growth12.8%
Revenue growth rate15.3%
Return on equity13.4%
Net Margin3.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

Nov 06
We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

Recent updates

We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

Nov 06
We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Sep 06
LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Sep 02
Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Jul 03
Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

Jun 08
Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

May 21
LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Apr 22
There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Revenue & Expenses Breakdown

How LBX Pharmacy Chain makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:603883 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2422,6288436,1002
30 Jun 2422,5669185,9962
31 Mar 2422,5369595,8662
31 Dec 2322,4379295,7633
30 Sep 2322,4418925,5363
30 Jun 2321,9958425,4733
31 Mar 2321,4758355,2852
31 Dec 2220,1767855,0132
30 Sep 2218,1927464,6490
30 Jun 2217,2267204,3580
31 Mar 2216,1986834,1730
31 Dec 2115,6966693,9950
30 Sep 2115,1286663,8640
30 Jun 2114,7416913,7350
31 Mar 2114,3236533,5870
31 Dec 2013,9676213,4920
30 Sep 2013,4136023,3852
30 Jun 2012,8165753,2422
31 Mar 2012,2185453,1762
31 Dec 1911,6635093,0741
30 Sep 1911,0695052,9500
30 Jun 1910,5674842,8496
31 Mar 199,9884642,7106
31 Dec 189,4714352,6096
30 Sep 189,0154212,4797
30 Jun 188,4844012,3441
31 Mar 187,9843882,2111
31 Dec 177,5013712,0681
30 Sep 177,0363631,9790
30 Jun 176,7803431,9010
31 Mar 176,4943311,8290
31 Dec 166,0942971,7480
30 Sep 165,6732851,6270
30 Jun 165,2502651,5260
31 Mar 164,8502541,4150
31 Dec 154,5682411,3370
30 Sep 154,3312261,2740
30 Jun 154,1782181,2220
31 Mar 154,0632121,1720
31 Dec 143,9432021,1260
31 Dec 133,3211618960

Quality Earnings: 603883 has high quality earnings.

Growing Profit Margin: 603883's current net profit margins (3.7%) are lower than last year (4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 603883's earnings have grown by 12.2% per year over the past 5 years.

Accelerating Growth: 603883's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 603883 had negative earnings growth (-5.5%) over the past year, making it difficult to compare to the Consumer Retailing industry average (6%).


Return on Equity

High ROE: 603883's Return on Equity (13.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 06:49
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LBX Pharmacy Chain Joint Stock Company is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yue GaoChangjiang Securities Co. LTD.
Qianyi LiChina International Capital Corporation Limited
Yong Jian LiChina Merchants Securities Co. Ltd.